Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cruickshank

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer|July 15, 1988
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-upI N Olver, M M Wolf, D Cruickshank, et al.
Pathology|July 1, 1986
Storage of platelet concentrates--an in vitro study of four types of plastic packsM A Quinn, J H Clyne, M M Wolf, et al.
Molecular Endocrinology (Baltimore, Md.)|January 8, 2005
Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitizationMin Pi, Robert H Oakley, Diane Gesty-Palmer, et al.
Assay and Drug Development Technologies|April 20, 2004
The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptorsRobert H Oakley, Christine C Hudson, Rachael D Cruickshank, et al.
American Journal of Human Genetics|April 1, 1993
Linkage studies with 17q and 18q markers in a breast/ovarian cancer familyB J Milner, L A Allan, K F Kelly, et al.
British Journal of Cancer|April 16, 2002
The level of haemoglobin in anaemic cancer patients correlates positively with quality of lifeM Lind, C Vernon, D Cruickshank, et al.
American Journal of Clinical Pathology|November 1, 1985
Acute changes in iron metabolism following myocardial infarctionJ D Griffiths, L J Campbell, I W Woodruff, et al.
British Journal of Cancer|February 1, 1992
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancerE M Rankin, L Mill, S B Kaye, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancerA R Clamp, J Mäenpää, D Cruickshank, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1993
The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological CancerP.M. Fayers, G. Rustin, R. Wood, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer|July 15, 1988
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-upI N Olver, M M Wolf, D Cruickshank, et al.
Pathology|July 1, 1986
Storage of platelet concentrates--an in vitro study of four types of plastic packsM A Quinn, J H Clyne, M M Wolf, et al.
Molecular Endocrinology (Baltimore, Md.)|January 8, 2005
Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitizationMin Pi, Robert H Oakley, Diane Gesty-Palmer, et al.
Assay and Drug Development Technologies|April 20, 2004
The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptorsRobert H Oakley, Christine C Hudson, Rachael D Cruickshank, et al.
American Journal of Human Genetics|April 1, 1993
Linkage studies with 17q and 18q markers in a breast/ovarian cancer familyB J Milner, L A Allan, K F Kelly, et al.
British Journal of Cancer|April 16, 2002
The level of haemoglobin in anaemic cancer patients correlates positively with quality of lifeM Lind, C Vernon, D Cruickshank, et al.
American Journal of Clinical Pathology|November 1, 1985
Acute changes in iron metabolism following myocardial infarctionJ D Griffiths, L J Campbell, I W Woodruff, et al.
British Journal of Cancer|February 1, 1992
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancerE M Rankin, L Mill, S B Kaye, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancerA R Clamp, J Mäenpää, D Cruickshank, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1993
The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological CancerP.M. Fayers, G. Rustin, R. Wood, et al.
Pageof 5